Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling ... Therapeutics entered an agreement with pharmaceutical company Incyte to use Genesis’ AI ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Novo Nordisk ( NVO) stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its ...
Novo’s share price fell 8 per cent on Monday, having previously dived in December after a late-stage trial of CagriSema in ...
AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra’s obesity drug. AI takes center stage at HIMSS ...
On this episode of This is Calgary, host Anis Heydari asks Councillors Courtney Walcott, Jasmine Mian and Evan ... Lilly plans to invest $27 billion in new US plants as Trump threatens ...
Under the terms of the deal, the pharmaceutical giant will pay Gubra ... to tamp down appetite and regulate blood sugar, while Eli Lilly's own drug Zepbound targets both GLP-1 and another hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback